APA (7th ed.) Citation

Y, L., F, W., Y, S., X, Z., C, D., Y, C., & N, L. (2025). First study on the efficiency of 99mTc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma. Annals of nuclear medicine, 39(4), 380. https://doi.org/10.1007/s12149-024-02012-5

Chicago Style (17th ed.) Citation

Y, Liu, Wang F, Song Y, Zhou X, Du C, Cui Y, and Li N. "First Study on the Efficiency of 99mTc-rituximab for Sentinel Lymph Node Mapping and Biopsy in Oral Squamous Cell Carcinoma." Annals of Nuclear Medicine 39, no. 4 (2025): 380. https://doi.org/10.1007/s12149-024-02012-5.

MLA (9th ed.) Citation

Y, Liu, et al. "First Study on the Efficiency of 99mTc-rituximab for Sentinel Lymph Node Mapping and Biopsy in Oral Squamous Cell Carcinoma." Annals of Nuclear Medicine, vol. 39, no. 4, 2025, p. 380, https://doi.org/10.1007/s12149-024-02012-5.